Technical information
Manufacturer
THERATECHNOLOGIES INTERNATIONAL LIMITED
Presentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
KcUTFg3yZTmtfFzc